SCHEMBL19984819

SCHEMBL19984819

Cc1ccc(C(c2ccccc2)C(O)I)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.44
CNR1 P21554 2/20 0.41
CNR2 P34972 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
KEAP1 Q14145 1/20 0.41
NFE2L2 Q16236 1/20 0.41
TSHR P16473 1/20 0.40
ALOX12 P18054 1/20 0.40
ACHE P22303 1/20 0.40
TACR1 P25103 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
OPRM1 P35372 1/20 0.38
OPRD1 P41143 1/20 0.38
OPRK1 P41145 1/20 0.38
OPRL1 P41146 1/20 0.38
HSD17B2 P37059 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19984820 0.87 LMNA (0.44) LMNAL3MBTL1TSHRKDM4EADRA2A
SCHEMBL17923689 0.82 LMNA (0.53) LMNACNR1CNR2TSHRALOX12
SCHEMBL12199145 0.82 LMNA (0.53) LMNACNR1CNR2TSHRALOX12
SCHEMBL15617630 0.81 LMNA (0.46) LMNACNR1CNR2L3MBTL1KEAP1
SCHEMBL29001569 0.79 LMNA (0.49) LMNACNR1CNR2KEAP1NFE2L2
SCHEMBL19984686 0.79 IDO1 (0.47) LMNACNR1CNR2L3MBTL1TSHR
SCHEMBL19984817 0.79 ACP3 (0.54) LMNACNR1CNR2L3MBTL1TSHR
SCHEMBL477385 0.78 LMNA (0.50) LMNACNR1CNR2L3MBTL1KEAP1
SCHEMBL477533 0.78 LMNA (0.50) LMNACNR1CNR2L3MBTL1KEAP1
SCHEMBL17118213 0.78 LMNA (0.48) LMNACNR1CNR2TSHRALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2306986-B1 PRODRUGS AND DRUG-MACROMOLECULE CONJUGATES HAVING CONTROLLED DRUG RELEASE RATES PROLYNX LLC (US) 2018-03-21 EP disclosed